Document Detail

Treatment of a viable caesarean scar pregnancy with transvaginal methotrexate and potassium chloride injection.
MedLine Citation:
PMID:  19360431     Owner:  NLM     Status:  MEDLINE    
PURPOSE: To present a case of an ectopic pregnancy in a previous caesarean scar in a woman who wishes to preserve her fertility, and its treatment with the local administration of potassium chloride (KCl) and methotrexate (MTX) via a transvaginal needle. CASE: A 35-year-old woman with a viable caesarean scar pregnancy was referred to our hospital. After an unsuccessful treatment attempt by administering 60 mg systemic methotrexate, the patient was treated with local administration of KCl and MTX using a transvaginal needle. The persistent ectopic mass was removed with dilatation and curettage (D&C) 1 week later. The patient had no complications and the treatment was successful in the follow-up examinations. CONCLUSION: Local MTX and KCl treatment using a transvaginal needle together with D&C can avoid unnecessary laparotomy, and helps to preserve the fertility of most women with a caesarean scar pregnancy.
Gokhan Goynumer; Canan Gokcen; Baki Senturk; Engin Turkgeldi
Publication Detail:
Type:  Case Reports; Letter     Date:  2009-04-10
Journal Detail:
Title:  Archives of gynecology and obstetrics     Volume:  280     ISSN:  1432-0711     ISO Abbreviation:  Arch. Gynecol. Obstet.     Publication Date:  2009 Nov 
Date Detail:
Created Date:  2009-09-25     Completed Date:  2010-01-28     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8710213     Medline TA:  Arch Gynecol Obstet     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  869-72     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Abortifacient Agents, Nonsteroidal / administration & dosage*
Administration, Intravaginal
Cesarean Section / adverse effects*
Cicatrix / complications*
Methotrexate / therapeutic use*
Potassium Chloride / administration & dosage*
Pregnancy, Ectopic / etiology,  therapy*
Reg. No./Substance:
0/Abortifacient Agents, Nonsteroidal; 59-05-2/Methotrexate; 7447-40-7/Potassium Chloride

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Matrix metalloproteinase-2 promoter variability in psoriasis.
Next Document:  Case report of fetal axillo-thoraco-abdominal cystic hygroma.